Lymphangiosarcoma: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 41: Line 41:
==Treatment==
==Treatment==
[[Lymphangiosarcoma medical therapy|Medical Therapy]] | [[Lymphangiosarcoma surgery|Surgery]] | [[Lymphangiosarcoma primary prevention|Primary Prevention]] | [[Lymphangiosarcoma secondary prevention|Secondary Prevention]] | [[Lymphangiosarcoma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Lymphangiosarcoma future or investigational therapies|Future or Investigational Therapies]]
[[Lymphangiosarcoma medical therapy|Medical Therapy]] | [[Lymphangiosarcoma surgery|Surgery]] | [[Lymphangiosarcoma primary prevention|Primary Prevention]] | [[Lymphangiosarcoma secondary prevention|Secondary Prevention]] | [[Lymphangiosarcoma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Lymphangiosarcoma future or investigational therapies|Future or Investigational Therapies]]
==Case Studies==
[[Lymphangiosarcoma case study one|Case #1]]


==Related Chapters==
==Related Chapters==

Revision as of 16:15, 11 September 2012

Template:DiseaseDisorder infobox Template:Lymphangiosarcoma

For patient information, click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Lymphangiosarcoma from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

Related Chapters


Template:WikiDoc Sources